We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specifi... CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. Show more
ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeuticsย (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
ZUG, Switzerland and BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeuticsย (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
ZUG, Switzerland and BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
โ CASGEVYโขย approved in theย U.S.,ย European Union, Great Britain, theย Kingdom of Saudi Arabiaย andย Bahrainย โ โ Clinical trials ongoing for next generation CAR T product candidates, CTX112โข and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.4 | -4.2735042735 | 56.16 | 58.675 | 52.75 | 1222953 | 55.25017636 | CS |
4 | -14.42 | -21.1498973306 | 68.18 | 68.389 | 52.75 | 1267686 | 60.05999536 | CS |
12 | -9.07 | -14.4357790864 | 62.83 | 91.1 | 52.75 | 1730481 | 73.6462647 | CS |
26 | 14.58 | 37.212863706 | 39.18 | 91.1 | 38.17 | 2345411 | 65.79959059 | CS |
52 | 4.16 | 8.38709677419 | 49.6 | 91.1 | 37.55 | 1740165 | 61.94945599 | CS |
156 | -74.46 | -58.0720636406 | 128.22 | 169.67 | 37.55 | 1498941 | 71.28796948 | CS |
260 | 14.14 | 35.6890459364 | 39.62 | 220.21 | 32 | 1346156 | 80.48964527 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions